Alan Colowick - Profile and Investment Details

Find investors who align with your industry, stage, and vision. Unlock Alan Colowick’s full investment profile, including location, investment focus, portfolio companies, and preferences. Sign up today and start building investor relationships that fuel your startup’s growth.

Get connected with all investors today
Investor type
Country
City/Area
Stages

-

Contacts
Available after registration.
Markets
Past investments
ENYO PharmaY-mAbs TherapeuticsNuCanaGloucester PharmaceuticalsHistogenicsAmplyx PharmaceuticalsSorbent TherapeuticsAnumanaMatrix Capital Management Company, L.P.AltPepVisen PharmaceuticalsnferenceVersartisAuris MedicalAerovate TherapeuticsMedeor TherapeuticsGuavusEdge TherapeuticsNorthSea TherapeuticsAthira PharmaAscendis PharmaAudentes TherapeuticsCinCor PharmaKaruna TherapeuticsBolt BiotherapeuticsHarpoon TherapeuticsPramanaVestagen Technical TextilesVelos BiopharmaInCarda TherapeuticsZiarcoPionyr ImmunotherapeuticsInvitaeAFYX TherapeuticsXyloCor TherapeuticsNateraLYSOGENENeurana PharmaceuticalsKiniksa PharmaceuticalsAeovian PharmaceuticalsPersonalis, Inc.Principia BiopharmaSolve Therapeutics, Inc.Innocoll HoldingsQuanta TherapeuticsAC ImmuneNuCana BioMedZS PharmaNextCureMaze TherapeuticsConteXtreamChiasmaAlumisAclaris TherapeuticsVera TherapeuticsCheckmate PharmaceuticalsFirst Aid Shot TherapyApellis PharmaceuticalsACELYRIN, INC.McPhyCivitas TherapeuticsCrocus TechnologyAtsena TherapeuticsHuman Longevity, Inc.Rainier TherapeuticsGalera TherapeuticsGyroscope TherapeuticsVelosBioAntiva BiosciencesIntrepida BioMerusMirna TherapeuticsAkouosCoherus BiosciencesAchaogen IncDimension TherapeuticsaTyr PharmaInozymeReCode TherapeuticsPromediorIterum TherapeuticsXyloCor Therapeutics, Inc.ObsEvaDauntless PharmaceuticalsSpark TherapeuticsEntasis Therapeutics
Investor Profile

Alan Colowick is a Venture Capital based in San Francisco, California, United States with a diverse investment portfolio that includes companies such as ENYO Pharma, Y-mAbs Therapeutics, NuCana, Gloucester Pharmaceuticals, Histogenics, Amplyx Pharmaceuticals, Sorbent Therapeutics, Anumana, Matrix Capital Management Company, L.P., AltPep, Visen Pharmaceuticals, nference, Versartis, Auris Medical, Aerovate Therapeutics, Medeor Therapeutics, GuavusEdge Therapeutics, NorthSea Therapeutics, Athira Pharma, Ascendis Pharma, Audentes Therapeutics, CinCor Pharma, Karuna Therapeutics, Bolt Biotherapeutics, Harpoon Therapeutics, Pramana, Vestagen Technical Textiles, Velos Biopharma, InCarda Therapeutics, Ziarco, Pionyr Immunotherapeutics, Invitae, AFYX Therapeutics, XyloCor Therapeutics, Natera, LYSOGENE, Neurana Pharmaceuticals, Kiniksa Pharmaceuticals, Aeovian Pharmaceuticals, Personalis, Inc., Principia Biopharma, Solve Therapeutics, Inc., Innocoll Holdings, Quanta Therapeutics, AC Immune, NuCana BioMed, ZS Pharma, NextCure, Maze Therapeutics, ConteXtream, Chiasma, Alumis, Aclaris Therapeutics, Vera Therapeutics, Checkmate Pharmaceuticals, First Aid Shot Therapy, Apellis Pharmaceuticals, ACELYRIN, INC., McPhy, Civitas Therapeutics, Crocus Technology, Atsena Therapeutics, Human Longevity, Inc., Rainier Therapeutics, Galera Therapeutics, Gyroscope Therapeutics, VelosBio, Antiva Biosciences, Intrepida Bio, Merus, Mirna Therapeutics, Akouos, Coherus Biosciences, Achaogen Inc, Dimension Therapeutics, aTyr Pharma, Inozyme, ReCode Therapeutics, Promedior, Iterum Therapeutics, XyloCor Therapeutics, Inc., ObsEva, Dauntless Pharmaceuticals, Spark Therapeutics, Entasis Therapeutics, . Over time, Alan Colowick has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Alan Colowick is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Genetics, Women Founded, Investment Management, Life Science, Biotechnology, Genomics, Medical, Therapeutics, Pharmaceuticals may find it worthwhile to explore potential connections with Alan Colowick, as their portfolio suggests a familiarity and interest in this area.

Understanding Alan Colowick’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.

Finally raise your round with Angel Match

Angel Match is the easiest way to research investors for your startup so you can spend less time Googling and more time raising.

Find the perfect investors today